A Clinical Trial of Treating Androgenic Alopecia with Mesenchymal Stem Cell Suspension Derived from Autologous Hair Follicle
Open Access
- 20 June 2023
- journal article
- research article
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 154 (3) , 444e-450e
Abstract
Background: Androgenic alopecia (AGA) is characterized by progressive hair follicle miniaturization. Novel treatments are needed to intervene in the miniaturization process. The authors aimed to evaluate the efficacy, safety, effectiveness, and effective population of autologous hair follicle mesenchymal stem cell therapy for the treatment of advanced AGA in Chinese individuals. Methods: Fifty patients ranging in age from 25 to 45 years (average, 32 ± 1.24 years) were included. None of them had ever used minoxidil, finasteride, or other drugs to promote hair growth. Healthy hair follicles were extracted from the occipital area and treated to obtain hair follicle mesenchymal stem cell suspensions. The recipient sites were divided into 2 groups. Nine points were injected in a 1-cm2 area, and 100 µL of solution containing either 1 × 105 cells or normal saline was injected at each point. The follow-up duration was 9 months. Observers were blinded to patient groupings and measurements. Results: An increased proportion of terminal hair and hair shaft diameter was observed in the experimental group at 1 month. The effect lasted for 3 months. The hair-thickening effect of advanced miniaturized hair follicles with hair shaft diameter less than 60 µm was more notable than that for above 60 µm. No patient experienced any obvious side effects. Conclusions: Hair follicle mesenchymal stem cells were effective in the treatment of advanced AGA in Chinese individuals. A hair shaft diameter of 60 µm can be used as a key index to predict the effectiveness of the therapy. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, II.Keywords
This publication has 15 references indexed in Scilit:
- Autologous cell–based therapy for male and female pattern hair loss using dermal sheath cup cells: A randomized placebo-controlled double-blinded dose-finding clinical studyJournal of the American Academy of Dermatology, 2020
- Dysfunction of Hair Follicle Mesenchymal Progenitors Contributes to Age-Associated Hair LossDevelopmental Cell, 2020
- Impact of the Different Preparation Methods to Obtain Human Adipose-Derived Stromal Vascular Fraction Cells (AD-SVFs) and Human Adipose-Derived Mesenchymal Stem Cells (AD-MSCs): Enzymatic Digestion Versus Mechanical CentrifugationInternational Journal of Molecular Sciences, 2019
- Guidelines for the diagnosis and treatment of male‐pattern and female‐pattern hair loss, 2017 versionThe Journal of Dermatology, 2018
- Evidence‐based (S3) guideline for the treatment of androgenetic alopecia in women and in men – short versionJournal of the European Academy of Dermatology and Venereology, 2017
- Hair follicle growth by stromal vascular fraction-enhanced adipose transplantation in baldnessStem Cells and Cloning: Advances and Applications, 2017
- Contribution of hair density and hair diameter to the appearance and progression of androgenetic alopecia in Japanese menBritish Journal of Dermatology, 2014
- Treatments for Androgenetic Alopecia and Alopecia AreataDrugs, 2001
- Finasteride in the treatment of men with androgenetic alopeciaJournal of the American Academy of Dermatology, 1998
- The unit area trichogram in the assessment of androgen-dependent alopeciaBritish Journal of Dermatology, 1983